Cogent Biosciences, Inc.·4

Jan 27, 4:58 PM ET

Robinson John Edward 4

4 · Cogent Biosciences, Inc. · Filed Jan 27, 2025

Insider Transaction Report

Form 4
Period: 2025-01-23
Robinson John Edward
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-01-23+270,000270,000 total
    Exercise: $8.89Exp: 2035-01-23Common Stock (270,000 underlying)
Footnotes (1)
  • [F1]This stock option shall vest in equal monthly installments over a four year period.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4